It probably could be updated into the 21st Century, and I would encourage Congress to maybe consider that.
I would be glad to be able to get that, because that may broaden out and accelerate some of the process as well.
How do you all deal with the moral issues and the ethical issues of leaving those that are getting the placebo--knowing ...
I am concerned that the FDA has a requirement and that they are trying to fulfill that requirement to be able to get the...
But only $2 billion in disbursements.
There is a difference between effective and duplicative.
So the 45 minutes is not just completing the form. It is gathering information.
When the first level is done and patients hear the stories--or people that are not patients hear the stories--this seems...
I have people in this study that are terminal, and that you are allowing the study to be able to go through, to the end,...
OK. Talk to me about the internal conversation about acceptable risk.
How do you track, at this point, research that would be done by the public sector and research that would be done only b...